$RXMD +4.27% at .061 and it's forming a base with the potential to break out higher on a move back above the .07 level. This follows another spectacular quarter with Q2 numbers out earlier this week. The company is also transitioning at the top spot, with a CEO change underway to position RXMD for an uplist onto a major exchange.

https://www.tradingview.com/chart/RXMD/vzHBfI...kout-Ahead